search
Back to results

Daily Protein Pacing Effects on HbA1c in Type 2 Diabetics

Primary Purpose

Type 2 Diabetes, HbA1c, Protein Intake

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PP
Sponsored by
Skidmore College
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • non-smoker
  • weight stable (+/-2kg) for at least 6 months prior to beginning the study
  • Pre-diabetic and Type 2 diabetic mellitus men and women with no known significant cardiovascular or metabolic diseases as assessed by a medical history and a comprehensive medical examination by their physicians
  • Sedentary or lightly active (<30 min, 2d/wk of structured physical activity) as assessed by a Physical Activity questionnaire

Exclusion Criteria:

  • Emphysema
  • Significant heart disease (CABG, CHF, VFib, Hypercholesterolemia, Uncontrolled High Blood Pressure, etc.)
  • COPD
  • Cancer or undergoing treatment for cancer
  • Allergies to milk or milk products, sugar alcohols, fructose, or gluten
  • Anorexia or Bulimia
  • Fasting intolerances/hypoglycemia
  • pregnant women or those looking to become pregnant

Sites / Locations

  • Human Nutrition and Metabolism Laboratory

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Protein Pacing

Standard Diet

Arm Description

During the 8 week trial, the Protein Pacing (PP) group will consume 3 daily servings of whey protein powder mixed with water at timed intervals: morning (0600-0800), afternoon (1000-1400), and evening (2000-2200) in addition to their normal food intake.

The participants in the CON will continue with their usual habitual dietary intake over the 8-week study and receive no intervention.

Outcomes

Primary Outcome Measures

Change in HbA1c
Quantify changes in HbA1c blood levels vja finger stick of 40ul or venipuncture blood draw of 5ml per visit (weeks 0, 4, and 8)

Secondary Outcome Measures

Change in total body fat and lean body mass
Quantitative measure of total body fat and muscle mass in kilograms using BODPod (air displacement plethysmography
Change in blood glucose, and lipids
Finger stick of 40ul or venipuncture blood draw of 5ml per visit (weeks 0, 4, and 8) to quantify changes in mg/dL
Change in physical activity
Quantitative measure of physical activity (kilocalories per day) using the ActiGraph accelerometer
Change in body weight
Quantitative measure of body weight in kilograms using a standard scale

Full Information

First Posted
April 20, 2022
Last Updated
April 12, 2023
Sponsor
Skidmore College
search

1. Study Identification

Unique Protocol Identification Number
NCT05355090
Brief Title
Daily Protein Pacing Effects on HbA1c in Type 2 Diabetics
Official Title
Effects of Daily Protein Supplementation for 8 Weeks on Improved Glucose, Insulin, and HbA1c Levels in Pre-Diabetics or Type 2 Diabetes Mellitus
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 6, 2022 (Actual)
Primary Completion Date
April 1, 2023 (Actual)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Skidmore College

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will examine the effects of protein (whey) supplementation added to the normal diet of pre-diabetes or diagnosed type 2 diabetes mellitus (T2DM) men and women on plasma glycated hemoglobin (HbA1c) and total body fat levels. Specifically, this study will directly quantify the impact of 3x/day timed ingestion of supplemental whey protein (20 grams of 80 calories per serving) added to the normal diet of free-living pre-diabetic or T2DM men and women over an 8-week study period on the major diagnostic outcome of pre-diabetic and T2DM (HbA1c levels) and total body fat levels. This study will quantify changes in HbA1C and total body fat levels in 24 pre-diabetics or T2DM participants.
Detailed Description
Previous investigations have demonstrated that simply adding 3 small protein feedings to the normal diet of overweight men and women, independent of caloric restriction and/or engaging in exercise training, significantly reduces body weight, fat mass, abdominal fat, waist circumference, and blood fat (triglyceride) levels (Arciero et al JAP, 2014), and confirms previous research (Baer et al, J Nutr, 2011). This timed ingestion is referred to as protein pacing (PP) and has been utilized in numerous scientific investigations with a great deal of success by the PI (see references). This one, simple, dietary modification, independent of reducing calorie intake and/or engaging in exercise training, is noteworthy and exceptional in terms of health improvements derived from diet alone. Unfortunately, the incidence and healthcare costs associated with type 2 diabetes mellitus (T2DM) are overwhelming. Currently, more than 34 million Americans have T2DM (1 in 10) and is increasing at alarming rates (>4.0%/year) among all segments of the population. Equally disturbing, T2DM costs the US more than $330 billion a year, including $237 billion in direct medical costs and $90 billion in reduced worker productivity. Thus, identifying evidence-based, effective, time-efficient, and easy-to-follow lifestyle strategies are vital to reducing these staggering healthcare costs and improving the health of T2DM patients. Indeed, lifestyle therapies remain the most effective treatments for T2DM outcomes. The purpose of this study is to examine the effects of protein (whey) supplementation added to the normal diet of pre-diabetes or diagnosed type 2 diabetes mellitus (T2DM) men and women on plasma glycated hemoglobin (HbA1c) and total body fat levels. Specifically, this study will directly quantify the impact of 3x/day timed ingestion of supplemental whey protein (20 grams of 80 calories per serving) added to the normal diet of free-living pre-diabetic or T2DM men and women over an 8-week study period on the major diagnostic outcome of pre-diabetic and T2DM (HbA1c levels) and total body fat levels. This study will quantify changes in HbA1C and total body fat levels in 24 pre-diabetics or T2DM participants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes, HbA1c, Protein Intake

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
24 volunteers with pre-diabetes or Type 2 diabetes mellitus (n=24) will be quasi-randomized to one of the two groups matched by sex (men/women) and body weight. Participants will be enrolled in the study as a single cohort and participate in a 8-week protein supplementation regimen consisting of three daily servings of whey protein along with their typical dietary intake.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Protein Pacing
Arm Type
Experimental
Arm Description
During the 8 week trial, the Protein Pacing (PP) group will consume 3 daily servings of whey protein powder mixed with water at timed intervals: morning (0600-0800), afternoon (1000-1400), and evening (2000-2200) in addition to their normal food intake.
Arm Title
Standard Diet
Arm Type
No Intervention
Arm Description
The participants in the CON will continue with their usual habitual dietary intake over the 8-week study and receive no intervention.
Intervention Type
Dietary Supplement
Intervention Name(s)
PP
Intervention Description
Protein Pacing three times per day
Primary Outcome Measure Information:
Title
Change in HbA1c
Description
Quantify changes in HbA1c blood levels vja finger stick of 40ul or venipuncture blood draw of 5ml per visit (weeks 0, 4, and 8)
Time Frame
0 and 4, and 8 weeks
Secondary Outcome Measure Information:
Title
Change in total body fat and lean body mass
Description
Quantitative measure of total body fat and muscle mass in kilograms using BODPod (air displacement plethysmography
Time Frame
0, 4 and 8 weeks
Title
Change in blood glucose, and lipids
Description
Finger stick of 40ul or venipuncture blood draw of 5ml per visit (weeks 0, 4, and 8) to quantify changes in mg/dL
Time Frame
0, 4 and 8 weeks
Title
Change in physical activity
Description
Quantitative measure of physical activity (kilocalories per day) using the ActiGraph accelerometer
Time Frame
0, 4, and 8 weeks
Title
Change in body weight
Description
Quantitative measure of body weight in kilograms using a standard scale
Time Frame
weeks 0, 4, and 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: non-smoker weight stable (+/-2kg) for at least 6 months prior to beginning the study Pre-diabetic and Type 2 diabetic mellitus men and women with no known significant cardiovascular or metabolic diseases as assessed by a medical history and a comprehensive medical examination by their physicians Sedentary or lightly active (<30 min, 2d/wk of structured physical activity) as assessed by a Physical Activity questionnaire Exclusion Criteria: Emphysema Significant heart disease (CABG, CHF, VFib, Hypercholesterolemia, Uncontrolled High Blood Pressure, etc.) COPD Cancer or undergoing treatment for cancer Allergies to milk or milk products, sugar alcohols, fructose, or gluten Anorexia or Bulimia Fasting intolerances/hypoglycemia pregnant women or those looking to become pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul J Arciero, PhD
Organizational Affiliation
Skidmore College
Official's Role
Principal Investigator
Facility Information:
Facility Name
Human Nutrition and Metabolism Laboratory
City
Saratoga Springs
State/Province
New York
ZIP/Postal Code
12866
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
27483317
Citation
Arciero PJ, Edmonds R, He F, Ward E, Gumpricht E, Mohr A, Ormsbee MJ, Astrup A. Protein-Pacing Caloric-Restriction Enhances Body Composition Similarly in Obese Men and Women during Weight Loss and Sustains Efficacy during Long-Term Weight Maintenance. Nutrients. 2016 Jul 30;8(8):476. doi: 10.3390/nu8080476.
Results Reference
background
PubMed Identifier
24833780
Citation
Arciero PJ, Baur D, Connelly S, Ormsbee MJ. Timed-daily ingestion of whey protein and exercise training reduces visceral adipose tissue mass and improves insulin resistance: the PRISE study. J Appl Physiol (1985). 2014 Jul 1;117(1):1-10. doi: 10.1152/japplphysiol.00152.2014. Epub 2014 May 15.
Results Reference
background
PubMed Identifier
23703835
Citation
Arciero PJ, Ormsbee MJ, Gentile CL, Nindl BC, Brestoff JR, Ruby M. Increased protein intake and meal frequency reduces abdominal fat during energy balance and energy deficit. Obesity (Silver Spring). 2013 Jul;21(7):1357-66. doi: 10.1002/oby.20296. Epub 2013 May 23.
Results Reference
background

Learn more about this trial

Daily Protein Pacing Effects on HbA1c in Type 2 Diabetics

We'll reach out to this number within 24 hrs